Jeff Thostenson
Overview
Explore the profile of Jeff Thostenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ryan S, Stanger C, Thostenson J, Whitmore J, Budney A
J Subst Abuse Treat
. 2012 Dec;
44(5):506-14.
PMID: 23228436
The current study examined the impact of disruptive behavior disorder (DBD) on substance use outcomes in an adolescent sample. Sixty-eight adolescents and their caregivers were randomized to one of two...
12.
Dersu I, Thostenson J, Durcan F, Hamilton S, Digre K
J Clin Neurosci
. 2012 Sep;
20(1):72-4.
PMID: 23014074
This study was conducted to determine whether the optic disc appearance and the visual field parameters of patients with migraine vary from those of age-matched controls. Twenty-two patients with migraine...
13.
Oliveto A, Poling J, Mancino M, Williams D, Thostenson J, Pruzinsky R, et al.
Addiction
. 2011 Jun;
107(1):131-41.
PMID: 21707811
Aims: Whether the selective serotonin re-uptake inhibitor sertraline at 200 mg/day delays relapse in recently abstinent cocaine-dependent individuals. Design: The study involved a 12-week, double-blind, placebo-controlled clinical trial with 2-week...
14.
Budney A, Fearer S, Walker D, Stanger C, Thostenson J, Grabinski M, et al.
Drug Alcohol Depend
. 2010 Dec;
115(1-2):74-9.
PMID: 21131143
The most potent outcomes for cannabis use disorders have been observed with a combination of three evidence-based interventions, motivational enhancement therapy (MET), cognitive-behavioral therapy (CBT), and abstinence-based contingency-management (CM). Access...
15.
Weinstein R, Wan C, Liu Q, Wang Y, Almeida M, OBrien C, et al.
Aging Cell
. 2010 Jan;
9(2):147-61.
PMID: 20047574
Aging or glucocorticoid excess decrease bone strength more than bone mass in humans and mice, but an explanation for this mismatch remains elusive. We report that aging in C57BL/6 mice...
16.
Plotkin L, Lezcano V, Thostenson J, Weinstein R, Manolagas S, Bellido T
J Bone Miner Res
. 2008 Jul;
23(11):1712-21.
PMID: 18597631
Connexin (Cx)43 is required for inhibition of osteocyte and osteoblast apoptosis by bisphosphonates in vitro. Herein, we evaluated its requirement for the in vivo actions of bisphosphonates using mice in...
17.
Thompson M, Henry-Tillman R, Margulies A, Thostenson J, Bryant-Smith G, Fincher R, et al.
Ann Surg Oncol
. 2006 Oct;
14(1):148-56.
PMID: 17058127
Background: Needle localization breast biopsy (NLBB) is presently the primary means of localizing non-palpable lesions. Disadvantages of NLBB include vasovagal episodes, patient discomfort, and miss rates. Because hematomas naturally fill...
18.
Bambha K, Kim W, Kremers W, Therneau T, Kamath P, Wiesner R, et al.
Am J Transplant
. 2004 Oct;
4(11):1798-804.
PMID: 15476479
We examined whether consideration of repeated model for end-stage liver disease (MELD) measurements for patients listed for liver transplantation improves predictive value beyond current MELD alone. Clinical data were extracted...